{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:48:54Z","timestamp":1790686134577,"version":"4.1.0"},"reference-count":31,"publisher":"American Society of Hematology","issue":"16","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,4,19]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>tMNs after ASCT originate from HSCs bearing (pre-)tMN mutations that are present years before disease onset. Post-ASCT treatment can influence selection and outgrowth of (pre)leukemic clones.<\/jats:p>","DOI":"10.1182\/blood-2017-09-805879","type":"journal-article","created":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T20:26:01Z","timestamp":1515443161000},"page":"1846-1857","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":36,"title":["Early detection and evolution of preleukemic clones in therapy-related myeloid neoplasms following autologous SCT"],"prefix":"10.1182","volume":"131","author":[{"given":"Gerbrig","family":"Berger","sequence":"first","affiliation":[{"name":"Department of Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie I.","family":"Kroeze","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresia N.","family":"Koorenhof-Scheele","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniek O.","family":"de Graaf","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroo","family":"Ueno","sequence":"additional","affiliation":[{"name":"Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Shiraishi","sequence":"additional","affiliation":[{"name":"Human Genome Center, Institute of Medical Science, the University of Tokyo, Tokyo, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Miyano","sequence":"additional","affiliation":[{"name":"Human Genome Center, Institute of Medical Science, the University of Tokyo, Tokyo, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"van den Berg","sequence":"additional","affiliation":[{"name":"Department of Genetics, University Medical Center Groningen, University of Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hein","family":"Schepers","sequence":"additional","affiliation":[{"name":"Department of Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert A.","family":"van der Reijden","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seishi","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edo","family":"Vellenga","sequence":"additional","affiliation":[{"name":"Department of Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joop H.","family":"Jansen","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"31","key":"2019111903454282800_B1","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1200\/JCO.2014.60.0890","article-title":"Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study","volume":"33","author":"Granfeldt \u00d8stg\u00e5rd","year":"2015","journal-title":"J Clin Oncol"},{"issue":"15","key":"2019111903454282800_B2","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1182\/blood-2012-08-448068","article-title":"Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008","volume":"121","author":"Morton","year":"2013","journal-title":"Blood"},{"issue":"1","key":"2019111903454282800_B3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(16)30626-X","article-title":"Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study","volume":"18","author":"Takahashi","year":"2017","journal-title":"Lancet Oncol"},{"issue":"12","key":"2019111903454282800_B4","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.4161\/cbt.26342","article-title":"Therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplantation in lymphoma patients","volume":"14","author":"Akhtari","year":"2013","journal-title":"Cancer Biol Ther"},{"issue":"14","key":"2019111903454282800_B5","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1200\/JCO.2016.71.6712","article-title":"Clonal hematopoiesis associated with adverse outcomes after autologous stem-cell transplantation for lymphoma","volume":"35","author":"Gibson","year":"2017","journal-title":"J Clin Oncol"},{"issue":"20","key":"2019111903454282800_B6","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"4","key":"2019111903454282800_B7","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1053\/j.seminoncol.2008.04.012","article-title":"Therapy-related myeloid leukemia","volume":"35","author":"Godley","year":"2008","journal-title":"Semin Oncol"},{"issue":"2","key":"2019111903454282800_B8","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1182\/blood-2011-07-367508","article-title":"Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies","volume":"119","author":"Kayser","year":"2012","journal-title":"Blood"},{"issue":"26","key":"2019111903454282800_B9","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"issue":"26","key":"2019111903454282800_B10","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"key":"2019111903454282800_B11","doi-asserted-by":"crossref","first-page":"12484","DOI":"10.1038\/ncomms12484","article-title":"Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults","volume":"7","author":"Young","year":"2016","journal-title":"Nat Commun"},{"issue":"8","key":"2019111903454282800_B12","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.celrep.2015.02.005","article-title":"Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis","volume":"10","author":"McKerrell","year":"2015","journal-title":"Cell Rep"},{"issue":"12","key":"2019111903454282800_B13","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/nm.3733","article-title":"Age-related mutations associated with clonal hematopoietic expansion and malignancies","volume":"20","author":"Xie","year":"2014","journal-title":"Nat Med"},{"issue":"1","key":"2019111903454282800_B14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1470-2045(16)30622-2","article-title":"Predicting therapy-related myeloid neoplasms-and preventing them?","volume":"18","author":"Steensma","year":"2017","journal-title":"Lancet Oncol"},{"issue":"1","key":"2019111903454282800_B15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S1470-2045(16)30627-1","article-title":"Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study","volume":"18","author":"Gillis","year":"2017","journal-title":"Lancet Oncol"},{"issue":"24","key":"2019111903454282800_B16","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1200\/JCO.2011.39.6820","article-title":"Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma: results of the randomized phase III HOVON-65\/GMMG-HD4 trial","volume":"30","author":"Sonneveld","year":"2012","journal-title":"J Clin Oncol"},{"issue":"2","key":"2019111903454282800_B17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1182\/blood-2007-08-108415","article-title":"Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed\/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial","volume":"111","author":"Vellenga","year":"2008","journal-title":"Blood"},{"issue":"7367","key":"2019111903454282800_B18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature10496","article-title":"Frequent pathway mutations of splicing machinery in myelodysplasia","volume":"478","author":"Yoshida","year":"2011","journal-title":"Nature"},{"key":"2019111903454282800_B19","doi-asserted-by":"crossref","first-page":"15099","DOI":"10.1038\/ncomms15099","article-title":"Clonal evolution in myelodysplastic syndromes","volume":"8","author":"da Silva-Coelho","year":"2017","journal-title":"Nat Commun"},{"issue":"12","key":"2019111903454282800_B20","doi-asserted-by":"crossref","first-page":"e1005657","DOI":"10.1371\/journal.pgen.1005657","article-title":"A simple model-based approach to inferring and visualizing cancer mutation signatures","volume":"11","author":"Shiraishi","year":"2015","journal-title":"PLoS Genet"},{"issue":"6","key":"2019111903454282800_B21","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3324\/haematol.2013.098103","article-title":"p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)","volume":"99","author":"Saft","year":"2014","journal-title":"Haematologica"},{"issue":"5","key":"2019111903454282800_B22","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1200\/JCO.2008.17.1033","article-title":"Accelerated telomere shortening precedes development of therapy-related myelodysplasia or acute myelogenous leukemia after autologous transplantation for lymphoma","volume":"27","author":"Chakraborty","year":"2009","journal-title":"J Clin Oncol"},{"issue":"5","key":"2019111903454282800_B23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ccr.2011.09.011","article-title":"Altered hematopoietic cell gene expression precedes development of therapy-related myelodysplasia\/acute myeloid leukemia and identifies patients at risk","volume":"20","author":"Li","year":"2011","journal-title":"Cancer Cell"},{"issue":"27","key":"2019111903454282800_B24","doi-asserted-by":"crossref","first-page":"6699","DOI":"10.1200\/JCO.2005.10.330","article-title":"Longitudinal assessment of hematopoietic abnormalities after autologous hematopoietic cell transplantation for lymphoma","volume":"23","author":"Bhatia","year":"2005","journal-title":"J Clin Oncol"},{"issue":"6","key":"2019111903454282800_B25","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nm.3155","article-title":"Chemotherapy-induced bone marrow nerve injury impairs hematopoietic regeneration","volume":"19","author":"Lucas","year":"2013","journal-title":"Nat Med"},{"issue":"7540","key":"2019111903454282800_B26","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nature13968","article-title":"Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia","volume":"518","author":"Wong","year":"2015","journal-title":"Nature"},{"issue":"4","key":"2019111903454282800_B27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.stem.2010.03.002","article-title":"p53-mediated hematopoietic stem and progenitor cell competition","volume":"6","author":"Bondar","year":"2010","journal-title":"Cell Stem Cell"},{"issue":"12","key":"2019111903454282800_B28","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.3324\/haematol.2013.086744","article-title":"Loss of quiescence and impaired function of CD34(+)\/CD38(low) cells one year following autologous stem cell transplantation","volume":"98","author":"Woolthuis","year":"2013","journal-title":"Haematologica"},{"issue":"18","key":"2019111903454282800_B29","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1182\/blood-2016-11-751008","article-title":"Somatic TP53 mutations characterize preleukemic stem cells in acute myeloid leukemia","volume":"129","author":"Lal","year":"2017","journal-title":"Blood"},{"issue":"6","key":"2019111903454282800_B30","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/leu.2016.345","article-title":"Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis","volume":"31","author":"Thol","year":"2017","journal-title":"Leukemia"},{"issue":"2","key":"2019111903454282800_B31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/131\/16\/1846\/1467985\/blood805879.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/131\/16\/1846\/1467985\/blood805879.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T08:46:18Z","timestamp":1574153178000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/131\/16\/1846\/36850\/Early-detection-and-evolution-of-preleukemic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,19]]},"references-count":31,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2018,4,19]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2017-09-805879","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,19]]}}}